Skip to main content

Table 1 Correlation between ENTPD5 expression and clinicopathological features of serous ovarian cancer patients

From: Knockdown of ENTPD5 inhibits tumor metastasis and growth via regulating the GRP78/p-eIF-2α/CHOP pathway in serous ovarian cancer

Clinicopathological features

ENTPD5 Expression level

Low

High

P Value

Ages(year)

 < 56

13

20

0.18

 ≥ 56

7

25

FIGO stage

I + II

9

5

 < 0.001***

III + IV

7

44

CA125(U/ml)

 < 600

11

27

0.71

 ≥ 600

9

18

Lymph node metastasis

Positive

8

11

0.2

Negative

12

34

Omentum metastasis

Positive

9

35

 < 0.01*

Negative

11

10

  1. *p < 0.01, ***p < 0.001